US FDA approves Zevra's treatment for rare genetic disease
The company has been trying for years to bring the drug to market after the U.S. health regulator previously declined to ...
Scientists synthesize a prebiotic carrier assists regorafenib in treating colorectal cancer
In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...
Recall alert: Dynacare Baby Powder recalled due to potential asbestos contamination
The Food and Drug Administration announced the recall of 62 cases of baby powder that could be contaminated with asbestos.
Dr. Reddy’s R&D centre in Hyderabad completes US FDA inspection
Dr. Reddy's Hyderabad R&D centre passes USFDA inspection with zero observations, ensuring compliance with GMP standards.
MedImmune Receives FDA Approval for Self-Administered Flu Vaccine
AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.
Dozens of Boar’s Head workers scrubbing plant infected by listeria — as company has no plans to reopen it
In an email to The Post this week, a Boar’s Head spokesperson said, “We do not currently have any plans to reopen this plant.
FDA Approves Zevra's Miplyffa for Niemann-Pick Disease Type C -- 2nd Update
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
US FDA approves AstraZeneca's flu vaccine for self-administration
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...